Fundz
Funding, M&A, exec moves and hiring — every signal, the moment it breaks.See plans →

Sentien Biotechnologies, Inc. announced it raised $1.05 Million in an initial filing from an offering of $1.2 Million

PRIVATEAug 12, 2015•almost 11 years ago

Amount Raised

$1.05 Million

Round Type

Seed

MassachusettsBiotechnology

Company Information

Company

Sentien Biotechnologies, Inc.

Location

Massachusetts, United States

About

A Medford, MA-based regenerative medicine company developing cell based therapies for acute organ failure

Predictive Intelligence
Strategic

ML-powered predictions for Sentien Biotechnologies, Inc.'s next move

Learn about Strategic plan

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching Sentien Biotechnologies, Inc.? See every signal — funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan